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Abstract 
The induction of synaesthesia in non-synaesthetes has the potential to illuminate the mechanisms that 
contribute to the development of this condition and the shaping of its phenomenology. Previous research 
suggests that lysergic acid diethylamide (LSD) reliably induces synaesthesia-like experiences in non-
synaesthetes. However, these studies suffer from a number of methodological limitations including lack 
of a placebo control and the absence of rigorous measures used to test established criteria for genuine 
synaesthesia. Here we report a pilot study that aimed to circumvent these limitations. We conducted a 
within-groups placebo-controlled investigation of the impact of LSD on colour experiences in response to 
standardized graphemes and sounds and the consistency and specificity of grapheme- and sound- colour 
associations. Participants reported more spontaneous synaesthesia-like experiences under LSD, relative to 
placebo, but did not differ across conditions in colour experiences in response to inducers, consistency of 
stimulus-colour associations, or in inducer specificity. Further analyses suggest that individual differences 
in a number of these effects were associated with the propensity to experience states of absorption in 
one’s daily life. Although preliminary, the present study suggests that LSD-induced synaesthesia-like 
experiences do not exhibit consistency or inducer-specificity and thus do not meet two widely established 
criteria for genuine synaesthesia.  
Keywords: colour; consciousness; consistency; hallucinogens; psychedelics; serotonin;  
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1. Introduction 
Synaesthesia is a neurological condition characterized by atypical binding in which a stimulus (inducer) 
will reliably and involuntarily elicit a secondary conscious experience (concurrent) (Ward, 2013). In 
congenital synaesthetes, for example, a particular number or auditory tone may automatically elicit a 
specific colour experience. Accumulating evidence from familial studies suggests that synaesthesia is 
hereditary (Barnett et al., 2008; Baron-Cohen, Burt, Smith-Laittan, Harrison, & Bolton, 1996) and there is 
preliminary research pointing to possible genetic polymorphisms underlying this condition (Asher et al., 
2009; Tomson et al., 2011). In contrast, the available evidence suggests that the particular inducer-
concurrent pairings that one experiences may be driven by environmental constraints (Witthoft & 
Winawer, 2013). Delineating the mechanisms underlying the development of synaesthesia has the 
potential to inform our broader understanding of numerous facets of cognition and perception including 
automaticity, binding, memory, and sensory processing (Cohen Kadosh & Henik, 2007; Ward, 2013).  
In recent years, there has been increased attention to the possibility of inducing synaesthesia or 
synaesthesia-like perceptual states in non-synaesthetes (Brogaard, 2013; Deroy & Spence, 2013; Luke & 
Terhune, 2013). One of the more striking instances of this includes the apparent induction through 
chemical agents of experiences that closely resemble synaesthesia. Indeed, there is reliable evidence that a 
number of different drugs, particularly tryptamines, which largely function as serotonin agonists (Nichols, 
2004), including lysergic acid diethylamide (LSD), psilocybin, and ayahausca, produce experiences that 
closely resemble synaesthesia, including the experience of colour in response to sounds (Hartman & 
Hollister, 1963; Kelly, 1934; Masters & Houston, 1966; Simpson & McKellar, 1955). However, a 
systematic review of these studies revealed that they suffered from numerous methodological limitations 
including the absence of placebo controls and the failure to use established behavioural measures of 
different features of synaesthesia including automaticity, inducer specificity, and consistency of inducer-
concurrent associations (Luke & Terhune, 2013). For these reasons, controversy persists as to whether 
these drug-induced experiences qualify as genuine synaesthesia (Deroy & Spence, 2013; Luke & 
Terhune, 2013; Sinke et al., 2012). 
Investigating LSD-induced synaesthesia 4 
Although complete consensus has not yet fully emerged regarding the adjudication criteria by which a 
phenomenon is identified as synaesthesia (e.g., Simner, 2012), the majority of researchers agree that an 
experience qualifies as synaesthesia if the inducer-concurrent mappings are (a) automatic; (b) consistent; 
(c) specific; and (d) accessible to consciousness (Ward, 2013). The aforementioned review (Luke & 
Terhune, 2013) found that research investigating the chemical induction of synaesthesia-like experiences 
had not formally tested whether any of the first three criteria were met, thus rendering it unclear how 
similar these phenomena are to genuine synaesthesia. 
The present study sought to replicate previous reports of LSD-induced synaesthesia-like experiences 
and determine whether they met the adjudication criteria of consistency and specificity. LSD was selected 
for this study because a survey of drug-users previously found that this drug was associated with the 
highest frequency of induced synaesthesia (Luke, Terhune, & Friday, 2012). Toward this end, as part of a 
larger placebo-controlled validation study of the feasibility of studying LSD in a neuroimaging 
environment (Carhart-Harris et al., 2015), participants rated the vividness of colour experiences and 
selected specific colours in response to a set of graphemes and sounds in LSD and placebo conditions. 
Participants also independently completed measures of absorption and visual imagery (Blajenkova, 
Kozhevnikov, & Motes, 2006; Jamieson, 2005; Ott, 2007; Tellegen & Atkinson, 1974), which may be 
related to the experience of drug-induced synaesthesia-like experiences (Studerus, Gamma, Kometer, & 
Vollenweider, 2012). We expected that LSD would produce synaesthesia-like experiences, particularly 
for sound stimuli, to a greater degree than placebo. We also sought to explore whether these experiences 
differed in consistency and inducer-specificity across conditions. 
 
2. Methods 
This study used a within-groups design involving the administration of LSD and a placebo on separate 
days. Here we report crucial features of the present study. The full methodological details of the study 
have been described in detail elsewhere (Carhart-Harris et al., 2015).  
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2.1. Participants. 
A convenience sample of 10 participants (one female; MAge=34.2±7.4, range = 26–47) consented to 
participate in this study. Participants were over the age of 21, did not have personal or immediate family 
history of a psychiatric illness, did not have a history of drug or alcohol dependence, or a medical 
condition that might render them unsuitable for participation in the study, based on self-reported 
information disclosed to a team psychiatrist. All participants had prior experience with a classic 
psychedelic drug, such as LSD, mescaline, or ayahuasca; this criterion was included to minimize the 
possibility of adverse responses to the drug. All participants were considered mentally and physically 
healthy in an examination by the psychiatrist. The study was approved by the NRES committee London, 
West London and was conducted in accordance with the revised Declaration of Helsinki (2000), the 
International Committee on Harmonisation Good Clinical Practice guidelines, and the NHS Research 
Governance Framework. Imperial College London sponsored the research and a Home Office license was 
obtained for research with a schedule one drug. Participants were informed that the study sought to 
determine an appropriate dose of LSD for a neuroimaging study and would involve completing a battery 
of psychological tasks. 
 
2.2. Materials 
2.2.1. Pre-experimental self-report measures. 
Participants completed a synaesthesia screening and two psychological measures prior to the experiment. 
 
Synaesthesia screening. 
Participants completed a questionnaire that defined synaesthesia and included examples of specific forms 
of synaesthesia and were asked whether they had any forms of synaesthesia. They were also asked 
whether they had experienced synaesthesia under the influence of any drugs, which drugs, and the 
frequency (rarely, some of the time, most of the time, every time), and the type of synaesthesia.  
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Psychological absorption. 
In a separate session, participants completed the modified version (MODTAS; Jamieson, 2005) of the 
Tellegen Absorption Scale (Tellegen & Atkinson, 1974). This 34-item scale taps a range of experiences 
pertaining to one’s propensity for having states of absorption characterized by intense attentional, 
affective, and perceptual involvement in activities. A representative item includes: “When I listen to 
music, I can get so caught up in it that I don’t notice anything else.” Items are scored on a 5-point likert 
scale with anchors of “never” and “very often”. The Cronbach’s α for this sample was .96, indicating 
strong internal consistency. 
 
Visual imagery. 
Participants also completed the Object-Spatial Imagery Questionnaire (OSIQ; Blajenkova et al., 2006), a 
30-item scale with a 5-point response format (“totally disagree” to “totally agree”). The OSIQ includes 
two 15-item subscales measuring object (“My images are very colourful and bright.”) and spatial (“I was 
very good in 3-D geometry as a student.”) visual imagery, both of which had good internal consistency 
(αs = .86 and .88, respectively). 
 
2.2.2. Experimental measures. 
Participants completed the following tasks and measures in each drug condition.  
 
Grapheme-colour associations. 
This task assessed the vividness of any colour experienced in response to graphemes and the consistency 
of grapheme-colour associations. Participants received the following instructions: “After looking at each 
symbol, choose a colour. If you experienced a colour whilst looking at the symbol then choose the colour 
nearest to that. If you didn't experience a colour then guess which colour might go best with that symbol.” 
Each trial consisted of a 1s fixation cross (in black against a gray background), followed by a 2s 
presentation of a grapheme (in black). Participants subsequently selected a colour from a 30×12 colour 
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palette and then judged their colour experience “What was your COLOUR experience when you saw the 
symbol?” using the Perceptual Awareness Scale (PAS; Sandberg, Timmermans, Overgaard, & 
Cleeremans, 2010), a four-point likert-type measure (1: “No experience”; 2: “Brief glimpse”; 3: “Almost 
clear image”; and 4: “Absolutely clear image”). Participants had unlimited time for the colour selection 
and experience judgment. Blocks consisted of 25 unique symbols: the digits 0-9 and the 15 most frequent 
letters in the English language (a, c, d, e, h, I, l, m, n, o, r, s, t, u, w; Lewand, 2000) presented in random 
order. After a 2s inter-block interval, participants completed a second block of trials with the same 
symbols in a different random order.  
 
Sound-colour associations. 
This task was formatted in the same way as the grapheme-colour association task, but included 24 unique 
sounds including eight vowel sounds (Moos, Smith, Miller, & Simmons, 2014); six pure tones (100, 200, 
400, 800, 1600, 3200 Hz); two further pure tone sounds (400Hz) that were louder and quieter; six 
complex sounds made up of a noise element (100-3200Hz bandpassed noise) and a tonal element (made 
up of sinusoids from 100Hz to 3200Hz in a geometric series) with the relative loudness of the noise 
varying; and two rapidly shifting sounds (one of which was the noise of a magnetic resonance imaging 
(MRI) T2 scan sequence). These sounds were previously used in studies of crossmodal sound-colour 
correspondences (Hamilton-Fletcher, 2015). Auditory stimuli were presented to participants using 
sandstorm SBS2112 sound system with the speakers placed in front of the participants 
 
Post-task questionnaire. 
To explore spontaneous synaesthesia-like experiences beyond colour, participants answered eight 
questions, administered in random order, after each task using a visual analogue scale with anchors at 
“strongly disagree” (0) and “strongly agree” (1) (see Table 1). They were subsequently asked if the 
graphemes/sounds triggered visual experiences that resembled a shown image (using the same scale). 
They were shown eight images consisting of six patterns linked by Klüver (Klüver, 1966), amongst others, 
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to psychedelic experiences (lattices, parallel lines, dots and flecks, zigzags, nested curves, and spirals) and 
two images that were included as controls (line drawings of faces and a rural landscape).    
 
2.3. Procedure 
Study sessions were conducted in the Wellcome Trust Clinical Research Facility (WTCRF) at the 
Hammersmith Hospital site, London. Participation involved two sessions separated by 5-7 days with 
placebo administered on the first visit (to avoid potential carry-over effects from LSD into the placebo 
condition); participants were unaware of the order and blind to the condition. Each testing session started 
between 10 and 11a.m.; participants were first briefed about the procedure and completed a urine test for 
drugs of abuse and a breathalyzer test for alcohol use. A medical doctor inserted and secured a cannula 
into a vein in the antecubital fossa and blood pressure was measured prior to dosing. Participants were 
encouraged to close their eyes and relax in a reclined position prior to the administration of a 10-ml 
solution of saline alone (placebo) or containing LSD (40–80 μg; one participant received 40, two 50, six 
70, and one 80 μg) intravenously infused over a 3 min period. Heart rate was measured throughout each 
testing session and recorded at 1-5 min intervals for the first 45 min post-infusion (monitoring phase); an 
experimenter also recorded self-ratings of the subjective intensity of the drug effects on an 11-point scale 
(0: “no effects” to 10: “extremely intense effects”). Participants subsequently completed the battery of 
psychological tasks, which included the present tasks and others (Carhart-Harris et al., 2015; Kaelen et 
al., 2015); heart rate and subjective ratings were recorded every 30-45 min for the remainder of the 
session. Stimulus presentation and response recording for the tasks was implemented with Psychopy v. 
1.80.01 (Peirce, 2007, 2008) on a HP 9470m notebook with a 14in. monitor. Participants started the tasks 
170±9min after drug administration; at that point, participants report drug intensity effects of 0±0 and 
6.1±0.8 in the placebo and LSD conditions, respectively. Participants were assessed by a psychiatrist for 
suitability of discharge after the subjective effects of LSD had sufficiently subsided (approximately 5-6 h 
post-infusion). 
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2.4. Analyses 
Inducer specificity 
To assess inducer specificity (i.e., the extent to which the same inducers produced colours on different 
occasions), we computed a measure of how reliably inducers elicited reports of colour experiences in the 
grapheme- and sound- colour tasks. Specifically, we calculated the absolute difference between colour 
experience (PAS) ratings for each stimulus pair (i.e., in block 1 and block 2) in each condition and task. 
In order to focus on subjective colour experiences, only stimulus pairs in which one member of each pair 
received a PAS rating of 2 (“brief glimpse”) or above were included; lower values reflect greater 
correspondence between colour experience ratings across the two presentations (i.e., greater inducer 
specificity). The proportion of stimulus ratings that were excluded from these analyses was greater 
(M±SE) in the grapheme task (placebo: .54±.10; LSD: .57±.12) than in the sound task (placebo: .39±.12; 
LSD: .32±.12), F(1,9)=5.38, p=.045, ηp2=.37, although proportions did not differ across conditions, 
F(1,9)=0.08, p=.78, ηp2=.01, and there was no Condition × Task interaction F(1,9)=1.40, p=.27, ηp2=.13.  
 
Stimulus-colour consistency 
Stimulus-colour consistency (i.e., the reliability with which graphemes and sounds were associated with 
the same colours on different trials) was indexed using an established measure of inducer-concurrent 
consistency (Eagleman, Kagan, Nelson, Sagaram, & Sarma, 2007). This measure is computed by 
averaging the geometric distance in RGB colour space for RGB values for each pair of stimuli presented 
across the two blocks in the sound and colour tasks (see also Rothen, Seth, Witzel, & Ward, 2013). Lower 
values reflect less colour distance across stimulus presentations and thus greater stimulus-colour 
consistency.  
 
Within-participant regression analyses  
These analyses sought to determine and whether, and to what extent, the experience of colour in response 
to graphemes and sounds was associated with greater grapheme- and sound- colour consistency. We 
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performed within-participant regression analyses in which consistency scores for each stimulus pair were 
regressed on the mean PAS scores (across the two presentations of a stimulus). This yielded an individual 
beta coefficient for each task and condition for each participant; negative coefficients indicate that greater 
colour awareness was associated with lower stimulus-colour consistency scores (reflecting greater 
consistency). 
 
Statistical Analyses 
All analyses were performed in MATLAB (2014a; The MathWorks Inc., Natick, MA, USA) or SPSS (v. 
20; IBM). Data were normally distributed (Kolmogorov-Smirnov test) in the inducer-specificity and 
inducer-concurrent consistency analyses. One or more variables included in the analyses of colour 
experiences, in the within-participant regression analyses, and in the analyses self-reported spontaneous 
experiences violated the assumption of distribution normality, primarily because of negatively skewed 
data. In all cases except self-reports of smell experiences, these violations were corrected through log 
transformations. Colour experience data (PAS scores) were pooled across blocks. Data were analyzed 
with 2 (Condition: placebo v. LSD) × 2 (Task: grapheme v. sound) repeated measures ANOVAs. Data 
were further analyzed using 2 × 2 ANCOVAs with the same factors and including self-report measures 
(see above) as continuous covariates in order to follow-up on previous research suggesting that such 
variables may moderate drug-induced synaesthesia (Studerus et al., 2012). 
 
3. Results 
3.1. Prior experience of drug-induced synaesthesia-like experiences 
Three of the 10 participants reported prior experience of drug-induced synaesthesia-like experiences. One 
reported sound-colour synaesthesia on psilocybin and ayahuasca; another reported sound-colour 
synaesthesia on LSD, and grapheme-colour synaesthesia on psilocybin; the third reported sound-colour 
synaesthesia on 2,5-dimethoxy-4-bromophenethylamine (2C-B), LSD, and ketamine. All three reported 
that these experiences occurred “some of the time”. One participant self-reported congenital grapheme-
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colour synaesthesia, but their data were in the range of the remaining participants in both placebo and 
LSD conditions and so were not treated differently. 
 
3.2. Stimulus-specific colour experiences under LSD 
The first analysis contrasted colour experiences in the different drug conditions and tasks using the PAS 
in a 2 (Condition: placebo v. LSD) × 2 (Task: grapheme v. sound) repeated measures ANOVA. Colour 
reports were numerically higher in the LSD condition, but there were neither main effects of Condition, 
F(1,9)=1.52, p=.25, ηp2=.14, or Task, F(1,9)=2.16, p=.18, ηp2=.19, nor an interaction F(1,9)=0.19, p=.67, 
ηp2=.02 (Fig. 1a). The inclusion of MODTAS and OSIQ subscale scores as covariates in an ANCOVA 
did not change this pattern and none of the measures was a significant covariate. These results suggest 
that participants did not report more colour experiences in response to graphemes and sounds in the LSD 
condition. 
 
 
 
Investigating LSD-induced synaesthesia 12 
 
Figure 1. Grapheme-colour and sound-colour association parameters as a function of drug. (a) Colour 
experiences (PAS); (b) Inducer specificity (average absolute PAS difference scores between stimulus 
presentations [lower values reflect greater specificity]); (c) Consistency of stimulus-colour associations 
(lower values reflect greater consistency); (d) Absorption (MODTAS) differentially correlated with LSD-
placebo differences in grapheme-colour and sound-colour consistency (residuals controlling for OSIQ 
object and spatial subscales); (e) Within-participant colour experience beta coefficients (in the prediction 
of stimulus-colour consistency) (negative values indicate that colour experience was associated with 
lower consistency scores [greater consistency]); (f) Absorption (MODTAS) positively correlated with 
colour experience beta coefficients collapsed across conditions (controlling for OSIQ object and spatial 
subscales) indicating that higher absorption is associated with a tendency for colour experience and 
consistency scores to be positively related [a negative association between colour experience and 
consistency]. 
 
3.3. Inducer specificity 
A core feature of congenital synaesthesia is that specific inducers will elicit particular concurrents. Here 
we sought to examine whether specific inducers consistently produced colour experiences. In the index of 
inducer specificity we developed, lower values reflect greater correspondence between colour experiences 
across the different presentations of a stimulus in a particular condition (greater specificity). Insofar as 
this analysis focused on inducers that elicited subjective colour experience (according to the PAS), we 
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excluded stimuli in which participants did not report any colour experiences on both presentations of the 
stimulus; accordingly, three participants were excluded from the analysis because they reliably had no 
colour experiences in at least one condition. As can be seen in Fig. 1b, inducer specificity scores were 
numerically lower in the LSD condition, but there were no main effects of Condition, F(1,6)=0.70, p=.44, 
ηp2=.10, or Task, F(1,6)=0.01, p=.92, ηp2<.01, nor an interaction, F(1,6)=0.48, p=.52, ηp2=.07. The 
inclusion of the self-report measures as covariates in an ANCOVA did not change this pattern and none 
of the measures was a significant covariate. This suggests that inducer-specificity did not change under 
LSD. 
 
3.4. Grapheme-colour and sound-colour consistency 
If LSD was inducing genuine synaesthesia, one might expect that grapheme-colour and sound-colour 
associations would be more consistent under LSD in comparison with placebo, as is observed in 
congenital synaesthetes relative to non-synaesthete controls (Eagleman et al., 2007; Rothen et al., 2013). 
Using an established measure of consistency (Eagleman et al., 2007), for which lower scores reflect 
greater consistency, participants displayed numerically higher scores in the LSD condition, but there 
were neither main effects of Condition, F(1,9)=2.77, p=.13, ηp2=.24, or Task, F(1,9)=.01, p=.93, ηp2<.01, 
nor an interaction, F(1,9)=0.75, p=.41, ηp2=.08 (Fig. 1c). When the three self-report measures were 
included as covariates, there was a Drug × Task × MODTAS interaction, F(1,6)=6.93, p=.039, ηp2=.54. 
This indicated that the tendency for LSD to increase grapheme-colour consistency scores (reflecting a 
decrease in consistency) relative to placebo, was more strongly correlated with a propensity for states of 
absorption, rp=-.67, p=.069, than the corresponding change in sound-colour consistency scores, rp=.40, 
p=.33 (Fig. 1d).  
A limitation of the foregoing analysis is that participants did not report synaesthetic experiences for 
all stimuli and changes in consistency scores could be blunted by the inclusion of inducer-concurrent 
pairings with and without concurrent colour experiences. Thus, we analyzed beta coefficients from 
within-participant regression analyses in which consistency scores were regressed on PAS scores. There 
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were no main effects of Drug, F(1,9)=0.68, p=.43, ηp2=.07, or Task, F(1,9)=0.26, p=.62, ηp2=.03, nor a 
Drug × Task interaction on beta coefficients, F(1,9)=1.38, p=.27, ηp2=.13 (Fig. 1e). Individual beta 
coefficients ranged from -.16 to .19 and across participants did not differ from 0 in any of the conditions, 
ts(9)<1.6, ps>.16, suggesting that the experience of colours in response to graphemes and sounds was 
unrelated to stimulus-colour mapping consistency. When this analysis was repeated including self-report 
measures as covariates in an ANCOVA, there was a main effect of MODTAS scores, F(1,6)=6.33, 
p=.046, ηp2=.51 (all other effects remained non-significant), reflecting a positive correlation between beta 
coefficients (collapsed across conditions) and MODTAS scores, rp=.72, p=.046 (Fig. 1f). This indicates 
that higher absorption was associated with a tendency for colour awareness to be associated with higher 
consistency scores (lower stimulus-colour consistency). Cumulatively, these results indicate that 
synaesthesia-like experiences are not more consistent under LSD than placebo and that stimulus-colour 
consistency is unrelated to the conscious experience of colours in response to inducers. They further 
suggest that proneness to absorption states may moderate the impact of different facets of stimulus-colour 
consistency. 
 
3.5. Stimulus-specific spontaneous experiences 
Our final analyses concerned eight types of spontaneous synaesthesia-like experiences during the 
grapheme and sound tasks (see Table 1). There were main effects of Drug on visual movements, 
F(1,9)=5.24, p=.048, ηp2=.37, experience of touch, F(1,9)=6.99, p=.027, ηp2=.44, and Klüver forms, 
F(1,9)=8.72, p=.016, ηp2=.49, with each being reported more frequently under LSD. In contrast, there 
were no Drug effects on visual patterns, F(1,9)=3.27, p=.10, ηp2=.27, projector-like visual experiences, 
F(1,9)=2.31, p=.16, ηp2=.20, or control visual forms (faces and landscapes), F(1,9)=1.25, p=.29, ηp2=.12.  
Independent of drug condition, sounds were more likely to elicit novel visual patterns, F(1,9)=13.65, 
p=.005, ηp2=.60, visual movements, F(1,9)=7.43, p=.023, ηp2=.45, and associator-like visual images, 
F(1,9)=23.20, p=.001, ηp2=.72. All other effects and interactions were non-significant, Fs<4.8, ps>.05. 
When the self-report measures (MODTAS and OSIQ) were included as covariates, participants were 
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suggestively more likely to report no visual experiences in the placebo condition, F(1,6)=4.93, p=.068, 
ηp2=.45, and to report projector-like visual experiences in the LSD condition, F(1,6)=4.42, p=.080, 
ηp2=.42. Taken together, these results point to a consistent trend for LSD to elicit stronger spontaneous 
synaesthesia-like experiences and further indicate that sounds are more likely than graphemes to elicit 
spontaneous visual experiences. 
 
 
Table 1. 
Descriptive statistics [M and (SD)] for spontaneous experiences as a function of Drug and Task. 
 Placebo LSD 
 Grapheme Sound Grapheme Sound 
The sounds/symbols triggered visual patterns .08 (.10) .26 (.24) .25 (.33) .46 (.39) 
The sounds/symbols triggered visual movement .03 (.05) .31 (.29) .31 (.39) .46 (.40) 
I didn’t really have any visual experiences in 
response to the sounds/symbols 
.82 (.20) .68 (.34) .70 (.34) .52 (.39) 
The sounds/symbols triggered visual 
experiences in my mind’s eyes 
.14 (.16) .42 (.33) .27 (.38) .43 (.41) 
The sounds/symbols triggered visual 
experiences that were projected externally 
.08 (.12) .18 (.27) .18 (.32) .26 (.36) 
The sounds/symbols triggered touch .05 (.08) .10 (.19) .19 (.32) .29 (.39) 
The sounds/symbols triggered smells .03 (.04) .08 (.13) .07 (.17) .09 (.24) 
The sounds/symbols triggered tastes .04 (.06) .09 (.11) .07 (.16) .09 (.23) 
Klüver forms (e.g., spirals) .09 (.16) .27 (.24) .23 (.26) .38 (.35) 
Control forms (e.g., faces) .08 (.13) .11 (.14) .17 (.33) .12 (.21) 
Note. Each item was scored on a visual analogue scale with higher values reflecting stronger endorsement 
of the respective experience. 
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4. Discussion 
This study sought to expand upon previous reports of LSD-induced synaesthesia-like experiences 
(Hartman & Hollister, 1963; Luke & Terhune, 2013; Masters & Houston, 1966; Simpson & McKellar, 
1955) by determining whether these experiences meet established criteria for synaesthesia in a within-
groups placebo-controlled design. Somewhat surprisingly, but consistent with the extant literature, LSD 
produced only weak spontaneous synaesthesia-like experiences relative to placebo. Neither consistency of 
stimulus-colour associations nor inducer specificity differed across drug conditions, suggesting that LSD-
induced synaesthesia-like experiences do not meet two established criteria for this condition (Ward, 
2013). These results demonstrate that the induction of synaesthesia-like experiences under LSD can be 
studied in a placebo-controlled design with established measures and hint at directions for further 
research.  
Previous research has documented how LSD and other tryptamines produce spontaneous perceptual 
states that closely resemble synaesthesia (for a review, see Luke & Terhune, 2013). In line with these 
studies, we observed a consistent tendency for participants to report spontaneous synaesthesia-like 
experiences, but not control percepts (e.g., faces), more frequently in the LSD condition in post-task 
questionnaires. In contrast, participants did not differ in the extent to which they experienced colours in 
response to the inducers in the different experimental conditions. In addition, they did not exhibit greater 
inducer-concurrent consistency or inducer specificity – two widely accepted criteria for synaesthesia – in 
the LSD condition, relative to the placebo condition. A number of possibilities may explain these 
discrepancies. First, it is possible that the dosages of LSD were not sufficiently high to produce 
synaesthesia although this seems unlikely given the dosages used and the drug intensity ratings and 
spontaneous experiences reported by participants. A second possibility is that participants believed that 
they had been administered LSD in the first session and then had expectancy-related changes in 
perceptual states or reported such changes due to demand characteristics, thus blunting any differences 
between the placebo and LSD conditions. However, none of the participants reported believing they had 
taken LSD in the placebo condition and self-reported drug intensity ratings in this condition were 
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uniformly at 0 at the time of task completion so this again seems highly unlikely. Third, it is plausible that 
drug-induced synaesthesia-like experiences are superficially similar to, but qualitatively distinct from, 
congenital synaesthesia and thus should not be expected to meet standard criteria for the latter. The 
present results are consistent with this interpretation and the related claim that the mechanisms and 
characteristics of drug-induced synaesthesia-like experiences are different from those of congenital 
synaesthesia (Deroy & Spence, 2013; Hubbard & Ramachandran, 2003; Sinke et al., 2012). This 
interpretation is perhaps further bolstered by the fact that participants were able to detect which condition 
they were in (see below) and yet still did not display response patterns similar to congenital synaesthetes.  
Another plausible explanation for the discrepant results is that our sample size did not offer sufficient 
statistical power to observe the induction of synaesthesia under LSD. Indeed, the effects of induced 
colour experiences and inducer specificity were in the direction predicted if LSD were producing genuine 
experiences and may have achieved statistical significance in a study with greater power. In contrast, 
consistency of stimulus-colour associations under LSD was not numerically greater than under placebo, 
although it is plausible that LSD impairs selective attention or attenuates distractor suppression (Carter et 
al., 2005; Wapner & Krus, 1960), which may interfere with response patterns on this task. Insofar as the 
same participants reported vivid visual experiences in response to music (Kaelen et al., 2015), it could be 
argued also that richer stimuli are required to induce synaesthesia under LSD than the simple stimuli used 
here, which are different from the stimuli that typically evoke synaesthesia under the influence of 
psychedelic drugs (Luke & Terhune, 2013). However, this may still represent a challenge to the 
hypothesis that these experiences qualify as synaesthesia because complex stimuli are not required for the 
induction of synaesthesia in congenital synaesthetes (Ward, 2013). Complicating matters further is that 
we observed heterogeneity in response to LSD with some participants exhibiting pronounced effects and 
others displaying only minimal responses. We provide some preliminary evidence that these effects are 
moderated by proneness to states of absorption, in line with previous research (Studerus et al., 2012). 
Further research in larger samples using counter-balanced designs, more variable doses, and stimuli of 
varying complexity will be necessary to better understand these effects.  
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A final explanation for our results may be that previous reports of psychedelic drug-induced 
synaesthesia were related to spontaneous occurrences of this phenomenon rather than its induction via 
stimuli in a controlled experimental paradigm. We have previously observed negligible effects of 
psychedelics on perceptual and physiological responses in other stimulus-response paradigms 
(Muthukumaraswamy et al., 2013), leading us to infer that the predominant (and indeed quintessential) 
effect of psychedelics is on spontaneous (i.e. on-going) processes, rather than induced responses. This is 
very much in keeping with the present results where participants reported spontaneous synaesthesia-like 
experiences. This situation presents a special challenge because stimulus-response paradigms benefit from 
high experimental control, which is why this approach was adopted here, but also because synaesthesia is 
typically regarded as a reliable stimulus-specific phenomenon. Unlike congenital synaesthesia, where the 
inducer plays an essential role, in psychedelic-induced synaesthesia-like experiences, transient 
fluctuations in perceptual states may be more critical. Certain scenarios (such as the present one) may 
demand that such experimental control be ceded in order to maintain the conditions in which the predicted 
phenomenon is intended to occur. Alternative techniques such as experiential-sampling (e.g., Kane et al., 
2007) could potentially be used to “capture” drug-induced synaesthesia-like experiences as they arise 
spontaneously. This approach could also be combined with simultaneous neuroimaging, with the aim of 
identifying the neural correlates of these phenomena. 
Our inducer-concurrent consistency results, in particular, have some potentially important 
implications. Inducer-concurrent consistency is a widely used, and highly robust, diagnostic marker of 
congenital synaesthesia (Eagleman et al., 2007; Rothen et al., 2013). In the present study, grapheme- and 
sound- colour associations did not differ in consistency across LSD and placebo conditions, with 
associations being actually numerically less consistent in the former condition, a result that is strongly at 
odds with the hypothesis that LSD is producing consistent synaesthesia-like experiences. We further 
examined whether experiencing colour in response to inducers was associated with greater stimulus-
colour consistency, but found no evidence for this, irrespective of drug condition or task. A notable result 
was that the propensity for experiencing states of absorption (Jamieson, 2005; Ott, 2007; Tellegen & 
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Atkinson, 1974) appeared to moderate individual differences in a number of facets of stimulus-colour 
consistency, including the extent to which colour experiences predict stimulus-colour consistency. 
Although they should be interpreted with caution, these correlations are potentially consistent with 
previous research showing that absorption predicts the occurrence of LSD-induced synaesthesia-like 
experiences (Studerus et al., 2012) and evidence indicating that synaesthetes score higher on 
psychometric measures of absorption (Chun & Hupe, 2015; Glicksohn, Steinbach, & Elimalach-
Malmilyan, 1999; Rader & Tellegen, 1987) and the related trait of openness to experience (Banissy et al., 
2013). However, the present results imply that individuals exhibiting high absorption who experience 
LSD-induced colours will exhibit reduced stimulus-colour consistency. Moreover, a potential confound 
that has yet to be addressed to our knowledge is that associations between absorption and synaesthesia or 
synaesthesia-proneness could be driven by the inclusion of items pertaining to crossmodal 
correspondences and synaesthesia-like experiences in the self-report measure of absorption, the 
MODTAS (e.g., Terhune, 2009). Further research on the induction of synaesthesia with pharmacological 
agents and other methods should follow up on such relations to better determine how absorption may 
facilitate synaesthesia-like experiences or covary with different facets of this condition.  
Cumulatively, the present results suggest that LSD-induced synaesthesia-like experiences do not meet 
two established criteria for synaesthesia: inducer-specificity and stimulus-colour consistency. Despite the 
need for caution given the likely under-powered nature of the statistical analyses, the current findings 
arguably challenge the possibility that LSD is inducing genuine synaesthesia (at least according to 
standard definitions of this condition) and thus the inclusion of such experiences in taxonomies of 
synaesthesia (Grossenbacher & Lovelace, 2001). Aside from a single critique (Simner, 2012), the 
criterion of inducer-concurrent consistency is perhaps the most well-agreed upon criterion of this 
condition. Nevertheless, we have previously argued that consistency might be too stringent of a criterion 
for transient forms, or early stages, of synaesthesia (Luke & Terhune, 2013). For instance, it is probable 
that consistency arises from the consolidation of inducer-concurrent pairings over time and thus will not 
be present at early stages. This hypothesis is consistent with research showing that congenital child 
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synaesthetes display lower consistency at earlier developmental stages (Simner & Bain, 2013; Simner, 
Harrold, Creed, Monro, & Foulkes, 2009). The same may apply to inducer-specificity. These factors 
complicate tests of the “genuineness” of ostensible synaesthesias, particularly those that are transient, and 
arguably render the absence of consistency and inducer-specificity effects inconclusive. One way of 
addressing this may be to couple cognitive training in stimulus-colour associations with the 
administration of LSD, although an early attempt in this direction with mescaline was unsuccessful 
(Kelly, 1934).  
In addition to the small sample size, an important limitation of this study is the ineffectiveness of the 
blind. In particular, all participants were able to identify which condition they were in (placebo v. LSD), 
thereby weakening the efficacy of the placebo-controlled design. This limitation is difficult to circumvent 
as the effects of LSD on conscious awareness are pronounced. Further research may benefit from 
contrasting LSD with other psychoactive substances that will produce alterations in conscious states but 
which are not expected to produce synaesthesia-like experiences, such as opiates (Luke et al., 2012). 
Nevertheless, this limitation arguably strengthens the interpretability of the null results. Specifically, 
insofar as participants were able to determine the drug condition, the demand characteristics in the LSD 
condition were probably much higher. Accordingly, the fact that no differences in consistency and 
inducer-specificity were observed under such circumstances suggests that LSD-induced synaesthesias do 
not produce such effects, as they were not even able to benefit from participants’ expectancies and the 
experimental demands. 
In summary, in a within-groups placebo-controlled study, we observed that LSD did not substantially 
alter the tendency to experience colour concurrents in response to sounds and graphemes and that 
stimulus-colour experiences under the influence of LSD did not meet accepted criteria for synaesthesia. 
Given the sample size of this study, these negative results should not be considered conclusive. 
Nevertheless, this study demonstrates the possibility of investigating the induction of synaesthesia with 
pharmacological agents in a controlled setting using rigorous measures. Although preliminary, our results 
suggest that LSD-induced synaesthesia-like experiences are qualitatively different from congenital 
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synaesthesia although they raise potentially important questions regarding the experimental study of such 
phenomena. 
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